TherapeuticsMD (TXMD) Current Leases (2019 - 2020)
TherapeuticsMD (TXMD) reported Current Leases of $2.3 million for Q4 2020, up 50.11% on a YoY basis from $1.5 million in Q1 2020, and down 6.25% quarter-over-quarter from $2.4 million in Q3 2020.
TherapeuticsMD (TXMD) Current Leases (2019 - 2020) Analysis & Trends
TherapeuticsMD has reported Current Leases for 2 years, with the latest figure at $2.3 million in Q4 2020.
- For the quarter ending Q4 2020, Current Leases rose 50.11% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2020 stood at $2.3 million (up 50.11% YoY), and the FY2020 full-year result was $2.3 million, up 50.11% from the prior year.
- Current Leases for Q4 2020 stood at $2.3 million, down from $2.4 million in the prior quarter.
- The five-year high for Current Leases was $2.4 million in Q3 2020, with the low at $1.2 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 5.58 Mn |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.25 Mn |
| Sep 30, 2020 | 2.40 Mn |
| Jun 30, 2020 | 2.11 Mn |
| Mar 31, 2020 | 1.75 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 1.24 Mn |
| Mar 31, 2019 | 1.16 Mn |